OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $349,907 Invested

2026

Columbia University Irving Medical Center

Chaolin Zhang, PhD

Novel ASO therapeutics to rebalance 3R/4R tau isoforms for frontotemporal dementia and other tauopathies

  • Funding Amount: $349,907
  • Organization Type:
  • Program: Drug Discovery
  • Target: Tau
  • Status: Active